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Hormone supplemented media for cloning human breast
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chemosensitivity
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Summary We tested the ability of hormones and growth factors to enhance the colony formation in soft
agarose of breast carcinoma using two human breast carcinoma cell lines, MCF-7 and MDA-MB231. MCF-7
could clone in a basal medium supplemented only by insulin, transferrin, prostaglandin F2., and fibronectin.
Combining oestradiol, dexamethasone, insulin, transferrin, and triiodothyronine with a basal medium
supplemented with 5% (v/v) foetal bovine serum (FBS) increased colony forming efficiency (CFE) two-to
three-fold over the best obtained in serum supplemented medium without hormones. While optimal CFE was
seen in the hormonally supplemented medium plus 5% FBS, clonal anchorage independent growth could also
be obtained without serum for both cell lines by substituting 0.5-1% (v/v) bovine serum albumin (BSA) for
FBS. Although CFE was enhanced with the addition of hormones, they did not substantially alter the in vitro
chemosensitivity patterns of the cell lines to 8 cytotoxic drugs. Hormonally-supplemented medium with 5%
FBS increased the CFE of a small number of fresh specimens of human breast cancer compared with medium
supplemented with serum alone. The systematic study of requirements for the in vitro growth of human breast
cancer may improve drug sensitivity testing by increasing our ability to grow this neoplasm in culture.
Although excellent palliation of patients with
metastatic breast cancer can be achieved with
existing therapies, the majority of patients will still
succumb to their disease. Therefore, new drugs and
new treatment strategies must be found. One
promising recent approach is the use of clonogenic
assays to predict chemosensitivity in the individual
patient (Salmon et al., 1978; Courtenay et al., 1978;
Carney et al., 1980; Von Hoff et al., 1981).
However, the success of the commonly used in vitro
assays requires the ability to clone human tumours
in semi-solid medium with a colony forming
efficiency (CFE) sufficiently high to permit accurate
analysis. At the present time, with standard culture
techniques, the CFE of most fresh tumour
specimens, including breast carcinoma, varies from
0.001-0.3%, permitting in vitro drug testing in only
20-35% of all specimens (Carney et al., 1981a,
Bertoncello et al., 1982; Pavelic et al., 1980;
Rupniak & Hill, 1980; Sandbach et al., 1982).
One approach to improve the anchorage
independent, clonal growth of human tumours is to
systematically analyze the nutritional requirements
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of a cell line of a particular type, as has been done
for Raji lymphoma cells (Ayres, 1982). We have
found that cell lines established from human
neoplasms such as the various histological types of
lung cancer tend to retain certain characteristics of
the parent tumour including nutritional
requirements and drug sensitivity profiles (Carney
et al., 1981b, 1982, 1983a). For breast cancer, the
established cell line MCF-7 has been used as a
model for many hormonal and nutritional studies,
as well as for development of in vitro
chemosensitivity testing (Soule et al., 1973; Elson et
al., 1982).
Because hormones are known to influence the
growth of breast carcinoma in vitro (Klevjer-
Anderson & Buehring, 1980), we decided to
undertake a study to improve the growth of human
breast carcinoma in agarose by adding hormones to
basal medium. Since hormones, particularly
oestradiol, may alter the chemosensitivity patterns
of these cells to cytotoxic agents, we also evaluated
the influence of hormone addition on chemo-
sensitivity. Using previously described serum-free
media which support the growth of human
mammary carcinoma cell lines in liquid culture
(Allegra & Lippman, 1978; Barnes & Sato, 1979), a
2-3 fold increase in the CFE in agarose of two
breast carcinoma lines with different estrogen
receptor status was obtained. CFE w 's also higher
in the hormonally-supplemented n'rdium for a
small number of fresh breast can ,r specimens.
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Despite the increase in CFE, in vitro chemo-
sensitivity of the cell lines to a variety of drugs was
similar in hormone supplemented and non-
supplemented medium.
Materials and methods
Cell lines
The human breast carcinoma lines MCF-7 (Soule et
al., 1973) and MDA-MB231 (Cailleau et al., 1974)
were kindly provided by Dr. M. Lippman, National
Cancer Institute, Bethesda, Maryland, and were
free of mycoplasma contamination (Microbiological
Associates, Bethesda, Maryland). MCF-7 was
established from a patient previously treated with
radiation and hormone therapy, and has receptors
for oestrogens, glucocorticoids, and insulin
(Horwitz et al., 1978). MDA-MB231 was
established from a patient previously treated with
chemotherapy, and these cells have receptors for
glucocorticoids- and insulin but not for oestrogens
(Horwitz et al., 1978). The two cell lines were
routinely maintained in Falcon plastic flasks (75sq.
cm.) at 37°C in 5% C02, 95% air, in Dulbecco's
minimum essential medium (DMEM) supplemented
with 10% foetal bovine serum (FBS) without
antibiotics. Cells were passaged weekly for MCF-7
and twice weekly for MDA-MB231 by
trypsinisation.
Culture media
The hormone supplemented media tested are listed
in Table I. Medium A, designed by Allegro &
Lippman (1978) to support the growth of the breast
cell line ZR-75-1, contains insulin, transferrin,
dexamethasone, triiodothyronine. and 17/
oestradiol. Medium B, designed by Barnes & Sato
(1979), supports the growth of MCF-7 in liquid
Table I Hormonally-supplemented medium
tested for ability to support cloning of breast
cancer
Media tested
Growthfactors A B
Insulin 3Mgml 1 250ngml
Transferrin 1 igml 1 25Mgml-
Prostaglandin F2. lOOngmlP'
Fibronectin 100ngmlP-
17,B oestradiol 10-8 M
Dexamethasone 10 8M
Triiodothyronine 10-8M
Basal medium DMEM DMEM/F12
cultures as a floating cell line. This medium was
slightly modified for these experiments and contains
insulin, transferrin, prostaglandin F2a,, and
fibronectin.
The medium in common use in the United States
for the human tumour stem cell assay (HTSCA
medium) (Soehnlen et al., 1981) was slightly
modified to exclude DEAE dextran and
mercaptoethanol from the overlayer and splenic
conditioned medium from the underlayer. In
addition, agarose was used in place of agar in both
layers.
DMEM, F12, McCoys 5A, and CMRL 1066
media, FBS, horse serum, trypsin-EDTA (0.5g
trypsin and 0.2g EDTA per litre in Hanks balanced
salt solution without Ca"+ and Mg"+), L-
glutamine, asparagine, L-serine, L-ascorbic acid,
and penicillin-streptomycin solution (penicillin
10000Uml-1, streptomycin 10000mcgmml1-) were
obtained from GIBCO Laboratories, Grand Island,
New York. Human transferrin, L-triiodothyronine,
bovine insulin, 17,B oestradiol, dexamethasone,
prostaglandin F2a, sodium pyruvate, and calcium
chloride were obtained from Sigma Chemicals, St.
Louis, MO. Tryptic soy broth was obtained from
DIFCO, Detroit, MI. Bovine albumin fraction V
was obtained from Miles Laboratory, Inc., Elkhart,
Indiana.
Soft agarose cloning experiments
Cells cultured in serum supplemented medium were
harvested in log phase growth with trypsin-EDTA,
washed twice in DMEM, and a single cell
suspension obtained by trituration; if clumps
persisted, single cells were obtained by passage
through 18-25 gauge needles. Cells were then
counted by haemocytometer and 104 viable cells (by
trypan blue exclusion) were suspended in the
medium being tested with 1% (v/v) penicillin-
streptomycin solution and 0.3% (v/v) agarose
(Seakem, Rockland, Maine) at 40°C. One ml of the
mixture was plated in triplicate in a 35mm plastic
petri dish containing a base layer of 0.5% agarose
in culture medium (v/v) that had hardened.
Cultures were incubated at 37°C in a humidified
atmosphere of 10% CO2, 90% air. The plates were
initially examined with an inverted phase
microscope to confirm that only single cells had
been plated. Colonies (>50 cells) were counted 12
to 15 days after plating and the CFE determined.
Each cloning experiment reported here was
performed 3 times, and the results given are the
means of these 3 values. For clinical specimens
(effusions), viable mononuclear cells were isolated
by density centrifugation using Ficoll-Hypaque
(Boyum, 1968; Katz & Lukeman, 1980). WeMEDIA FOR CLONING HUMAN BREAST CANCER 685
obtained a single cell suspension by passage
through 18-25 gauge needles, and then plated 105
viable mononuclear cells per dish.
In vitro chemosensitivity
The in vitro sensitivities of the cell lines to eight
cytotoxic agents were determined as previously
described (Salmon et al., 1978; Von Hoff et al.,
1981). Cells (104) were incubated for 1 h in DMEM
at 37°C with 3 different drug concentrations:
clinically achievable peak plasma concentration,
and 10% and 1% of this concentration. After
incubation, the cells were washed twice in DMEM
and plated as described above. Sensitivity was
defined as a 70% reduction of colony number after
1 h exposure to 10% peak plasma concentration, or
0.3 pgml- 1 for methotrexate, 0.06 pgml-1 for
adriamycin, O.l pgml-1 for vincristine, 0.5pgml-'
for vinblastine, 6 pgml-1 for 5-fluorouracil,
0.25 pgml- 1 for melphalan, 0.2 pgml-1 for cis-
platinum, and 0.1 pgml for mitomycin C (Alberts
& Chen, 1981).
Results
Soft agarose cloning
The CFE of the two cell lines in different media is
shown in Tables II and III. The optimal
concentration of FBS when used as the only
supplement to the basal medium (DMEM) was
10% (Table II). In DMEM+10% FBS, CFE was
4.9% for MCF-7 and 4.0% for MDA-MB231.
Neither cell line could clone in serum-free
medium A alone, but MCF-7 did clone in serum-
free medium B although CFE was low at 0.3%.
MDA-MB231 could not clone in either serum-free
medium without further supplementation (Table II).
The optimal concentration of FBS when used to
further enrich hormone-supplemented medium (A
or B) was 5% (Table II). In medium A+ 5% FBS,
CFE was 8.6% for MCF-7 and 10.8% for MDA-
MB231. This represents a 2-fold increase for MCF-
7 and a 3-fold increase for MDA-MB231 over the
optimal CFE obtained without hormonal
supplementation. Even the addition of 1% FBS
enhanced colony formation, particularly with
medium B. Adding more than 5% FBS to the
defined media led to decreased CFE, falling to
<0.5% with 40% FBS.
Some colony formation was obtained with both
cell lines in modified HTSCA medium, but CFE
was only 0.15% for MCF-7 and 0.1% for MDA-
MB231 (Table II). We see that the CFE of MCF-7
and MDA-MB231 in modified HTSCA medium
was much less than that obtained with the optimal
Table II Colony forming efficiencya of MCF-7
and MDA-MB231 in different media supplemented
with fetal bovine serum (FBS)
Cell lines
Growth conditions MCF-7 MDA-MB231
DMEM+FBS (%) <0.01 <0.01
1 <0.01 <0.01
5 4.7+1.7 3.7+1.5
10 4.9+1.1 4.0+0.8
20 4.4+1.4 2.7+0.7
40 0.5+0.3 0.6+0.1
Medium A <0.01 <0.01
1 0.3+0.1 0.3+0.1
5 8.6+2.0 10.8+2.0
10 7.4+ 1.3 8.7+0.6
20 6.8+0.8 6.3+1.4
40 0.6+0.2 0.05
Medium B 0.3+0.1 <0.01
1 7.6+1.2 8.4+1.6
5 7.5+1.6 9.5+1.2
10 5.6+0.9 6.4+ 1.5
20 5.4+0.6 4.4+ 1.7
40 0.3+0.2 0.05
HTSCA medium
(modified) 0.15 0.1
aColony forming efficiency=(Number of colonies
x 100)/(No. of cells plated). Values given are
means +s.d.
combination of hormonal supplementation and
small volumes of foetal calf serum.
We next tested the ability of bovine serum
albumin fraction V (BSA) to substitute for FBS
(Table III). CFE for MCF-7 was 7.9% in medium
A+1% BSA and was 3.5% for MDA-MB231 in
medium A+ 1% BSA. Thus, hormonally-
supplemented medium plus an optimal
concentration of BSA gave a higher CFE for MCF-
7 and a similar CFE for MDA-MB231 compared
to DMEM +10% FBS without hormonal
supplementation.
Having demonstrated that high CFE of the
breast cancer cell lines was obtained in medium A
or medium B supplemented with 5% FBS, we next
tested the ability of these combinations to support
the soft agarose colony formation of three fresh
specimens of human breast carcinoma, compared to
modified HTSCA medium and to DMEM + 10%
FBS. Results are shown in Table IV. Medium
A+5% FBS was clearly superior to the 3 other
conditions tested with these fresh specimens.
Cytology of the colonies of the different samples
showed typical adenocarcinoma morphology.686 F. CALVO et al.
Table III Colony forming efficiencya of MCF-7
and MDA-MB231 in different media supplemented
with bovine serum albumin
Cell lines
Growth conditions MCF-7 MDA-MB231
DMEM+ 10% FCS 4.9+ 1.1 4.0+0.8
DMEM+BSA (%) <0.01 <0.01
0.5 0.07+0.02 <0.01
1 0.1+0.05 <0.01
2 <0.01 <0.01
Medium A <0.01 <0.01
0.5 6.4+0.7 0.1+0.03
1 7.9+1.1 3.5+0.7
2 5.4+0.5 0.5+0.2
Medium B 0.3+0.1 <0.01
0.5 4.2+0.8 3.9+1.4
1 3.2+0.5 0.6+0.2
2 0.9+0.2 0.7+0.3
aColony forming efficiency=(Number of
colonies x 100)/(No. of cells plated). Values given
are means +s.d.
Table IV Number of colonies obtained in different
media with three fresh specimens of human breast
carcinoma
Condition tested
DMEM Medium A Medium B
Tumour Modified + 10% +5% +5%
specimen HTSCA FBS FBS FBS
1. Pleural fluid 15 5 200 35
2. Pleural fluid 0 0 103 0
3. Ascites 0 0 214 0
Values given are the mean number of colonies of >50
cells obtained after plating 10 viable nucleated cells in
triplicate.
In vitro chemosensitivity studies
After exposure to drug for 1 h as described in
Materials and methods, cells were plated in either
DMEM+10% FBS, or in defined medium (A or
B)+5% FBS. Colony survival for the 2 cell lines
after exposure to 5 fluorouracil, vincristine, and
adriamycin in the different media are shown in
Figure 1. No substantial difference was observed
between the results of the drug testing in the
different media for these three drugs. Both cell lines
MCF7 CELL LINE
100 -.
50 ADRIAMYCIN
'
0.006 0.06 0.6
MDA-MB231 CELL LINE
100 E
50 ADRIAMYCIN
0.006 0.06 0.6 0-
-5
0
'5
L)
100 £~ Z1.
50 - VINCRISTINE -
0.001 0.01 0.1
pg ml-1
100 if A- i
50 VINCRISTINE
0.001 0.01 0.1
pg mI-1
Figure 1 Colony survival of MCF-7 and MDA-MB
231 cell lines after one hour exposure to various
concentrations of drugs in different media (U ---U
DMEM supplemented with 10% foetal bovine serum,
$& * medium A, supplemented with 5% foetal
bovine serum, A A medium B supplemented with
5% foetal bovine serum).
were also resistant in vitro in all 3 conditions to 1 h
exposure at 10% of peak achievable plasma level of
melphalan, mitomycin C, vinblastine, cis-platinum,
and methotrexate.
Discussion
In this study, we have demonstrated that the in
vitro soft agarose cloning of established cell lines of
human breast carcinoma can be substantially
increased by the addition of hormones including
17# oestradiol to the culture medium, without
altering the drug sensitivity of the cell lines to
cytotoxic agents including adriamycin, melphalan,
methotrexate, vincristine, vinblastine, cis-platinum,
and mitomycin C.
Our work was based in part on principles of
serum-free cell culture (Barnes & Sato, 1980a,
1980b). In liquid culture, hormonally-supplemented,
serum-free media may have certain advantages over
conventional serum-supplemented medium
including increased selectivity for the growth of
tumour cells in fresh specimens (Carney et al.,
1981b) and avoidance of competitive or inhibitory
effects of various undefined hormones contained inMEDIA FOR CLONING HUMAN BREAST CANCER 687
serum. However, soft agarose cloning is markedly
inferior in serum-free medium with these breast
cancer cell lines, suggesting that some factors
present in FBS or BSA are necessary for optimal
soft agarose cloning of the cell lines. Lymphoid
cells also clone poorly in serum-free medium
without BSA, and it has recently been suggested
that the function of the BSA may be to serve as a
free radical scavenger, preventing hydrogen
peroxide toxicity (Darfler & Insel, 1983).
The ability of MCF-7 to clone at all in defined
medium without FBS or BSA is significant. It
suggests that this cell line is able to produce factors
needed for its own anchorage independent growth.
Production of autocrine growth factors may be an
explanation for the reduced serum requirement for
certain transformed cells (Kaplan et al., 1982). We
have demonstrated autocrine growth factor
production by human small cell lung cancer cell
lines (Carney et al., 1983b). Only small volumes of
FBS or BSA were needed to achieve peak CFE of
the cell lines when added to the defined media;
higher concentrations decreased colony formation,
suggesting that FBS or BSA also contain factors
inhibitory to cell cloning. We found that the
optimal concentration of animal serum for cloning,
5% was substantially lower than that used in other
in vitro clonogenic assays. The poor CFE of 0.15%
that we obtained for MCF-7 with modified HTSCA
medium, which includes 15% animal serum, is quite
similar to the cloning efficiency of 0.066% reported
for MCF-7 from the University of Arizona with
another version of HTSCA medium (Pathak et al.,
1982).
Serum-free media have been developed for many
of the common forms of human neoplasia, based
on analysis of the growth factor requirements for
these tumours in liquid culture (Simms et al., 1980;
Barnes et al., 1981). It is conceivable that the
optimal cloning medium for each tumour type may
be provided by combining such defined media with
small amounts of animal serum to provide the as
yet unknown factors needed for anchorage
independent growth. McClure (1983) has reported
that anchorage independent growth of SV-40
transformed fibroblasts can be markedly enhanced
by adding specific serum components such as
fibronectin or platelet derived growth factor to a
simple basal serum-free medium.
While the number of specimens was small, our
work with three fresh pleural fluids does suggest a
possible advantage in the use of the hormonally-
supplemented media we devised by analyzing the
nutritional requirements of human tumour cell
lines. Further analysis of these nutritional
requirements may permit us to determine which of
the individual factors in medium A and medium B
are most responsible for the stimulation of growth
we observed. The lack of alteration in the in vitro
chemosensitivity in the two cell lines in hormonally-
supplemented medium suggests that these cloning
media will not artifactually alter drug testing data
obtained with fresh specimens, although this
remains to be tested.
The use of in vitro clonogenic assays is
undergoing a major reassessment (Lieber &
Kovach, 1982; Selby et al., 1983). There are many
technical problems with such assays, including the
difficulty of obtaining true single cell suspensions
(Agrez et al., 1982), but there are data to suggest
that culture conditions such as oxygen tension play
an important role in the growth of malignant cells
in semi-solid medium (Courtenay et al., 1978; Tveit
et al., 1981). The identification of the specific
growth requirements of individual tumour types
may enhance our ability to obtain sufficient
numbers of colonies from clinical specimens for
routine in vitro drug testing. In addition, the ability
to clone cell lines in serum-free medium may assist
in our understanding of hormonal regulation of
tumours, including possible autocrine regulatory
mechanisms in human breast cancer.
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